Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 4;58(7):896.
doi: 10.3390/medicina58070896.

Autoimmune Hepatitis-Challenging Diagnosis

Affiliations
Case Reports

Autoimmune Hepatitis-Challenging Diagnosis

Aleksandra Mroskowiak et al. Medicina (Kaunas). .

Abstract

The incidence of Autoimmune Hepatitis (AIH) increases worldwide. If undiagnosed, it may progress end-stage liver disease. Unfortunately, there is no characteristic clinical presentation of this disease, which makes the illness hard to recognize. A case report illustrates the difficulties of diagnosing the patient during his two hospitalizations and his final treatment with prednisolone which improved the patient's condition.

Keywords: AIH; Autoimmune Hepatitis; antibody; immunoglobulin; steroids.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure A1
Figure A1
Pictures (AF) Diagnostic imaging. (A) A polyp in the gallbladder shown in the ultrasound examination of the abdomen. (B) Hepatic steatosis of the liver shown in the ultrasound examination of the abdomen. (C) Enlarged liver shown in the abdominal CT scan with contrast. (D) Hepatic steatosis shown in the abdominal CT scan with contrast. (E) A polyp in the gallbladder shown in the abdominal CT scan with contrast. (F) Homogeneous intraluminal signal of the lumen of the portal vein shown in the abdominal CT scan with contrast.
Figure A2
Figure A2
Pictures (ag): Histopathological images of the patient’s liver. (a) Hematoxylin and eosin stain: Extensive mixed-cells infiltration bundant mixed-cells infiltration with a predominance of lymphocytes and plasma cells in the portabiliary area, periportal areas and intrahepatic trabecula. (b) Selective stain: paS (+). (c) Selective stain: glycogen (+). (d) Selective stain: Masson’s trichrome (+). (e) Immunohistochemical reaction LCA (+) in the inflammatory infiltrates. (f) Immunohistochemical reaction IgG (+). (g) Immunohistochemical reaction IgM (+).

References

    1. Krawitt E.L. Autoimmune Hepatitis. N. Engl. J. Med. 2006;354:54–66. doi: 10.1056/NEJMra050408. - DOI - PubMed
    1. Tanaka A. Autoimmune Hepatitis: 2019 Update. Gut Liver. 2020;14:430–438. doi: 10.5009/gnl19261. - DOI - PMC - PubMed
    1. Heneghan M.A., Yeoman A.D., Verma S., Smith A.D., Longhi M.S. Autoimmune Hepatitis. Lancet. 2013;382:1433–1444. doi: 10.1016/S0140-6736(12)62163-1. - DOI - PubMed
    1. Bridoux—henno L., Maggiore G., Johanet C., Fabre M., Vajro P., Dommergues J.P., Reinert P., Bernard O. Features and outcome of Autoimmune Hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody. Clin. Gastroenterol. Hepatol. 2004;2:825–830. doi: 10.1016/S1542-3565(04)00354-4. - DOI - PubMed
    1. Komori A. Recent updates on the management of Autoimmune Hepatitis. Clin. Mol. Hepatol. 2021;27:58–69. doi: 10.3350/cmh.2020.0189. - DOI - PMC - PubMed

Publication types

LinkOut - more resources